NXGL
NEXGEL, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.27
+2.63%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.24
- Revenue estimate
- $4.2M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.40
- EPS estimate
- -$0.12
- Revenue actual
- $3.7M
- Revenue estimate
- $4.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -281.0%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.12 | -$0.40 | Miss -233.33% | $3.7M |
| May 15, 2026 | -$0.07 | -$0.11 | Miss -57.14% | $2.6M |
| Mar 31, 2026 | -$0.09 | -$0.12 | Miss -33.33% | $2.8M |
| Aug 12, 2025 | -$0.01 | -$0.09 | Miss -800.00% | $2.9M |
| Mar 24, 2025 | -$0.10 | -$0.08 | Beat 20.00% | $3.0M |
| Aug 19, 2024 | -$0.14 | -$0.14 | In line | $1.4M |
| Apr 1, 2024 | -$0.11 | -$0.19 | Miss -72.73% | $1.1M |
| Nov 13, 2023 | -$0.12 | -$0.10 | Beat 16.67% | $1.2M |
| Aug 14, 2023 | -$0.13 | -$0.12 | Beat 7.69% | $1.2M |
| May 15, 2023 | -$0.14 | -$0.15 | Miss -7.14% | $620.0K |
| Aug 10, 2022 | -$0.15 | -$0.19 | Miss -26.67% | $561.0K |
| May 12, 2022 | -$0.15 | -$0.33 | Miss -120.00% | $396.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026